ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
January 21, 2022HanAll Biopharma (KRX: 009420.KS) announced today that it achieved 101.6 billion won in sales in 2021, a 15% increase from the previous year. It had 10.1 billion won in operating profit, a 70% increase year-on-year... -
HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Bi
September 12, 2017HanAll Biopharma Co., Ltd. (009420.KS) and Harbour BioMed announced today that they have entered into a strategic collaboration and license agreement to develop
Pharma Sources Insight January 2025
